Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02536352 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being
A Early Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 43
- Enrollment target
NCT02536352: Completed Early Phase 1 study, sponsored by Johns Hopkins University.
NCT02536352 is a Early Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02536352, a Early Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 43 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether fluoride supplementation during pregnancy is effective in extending the length of gestation and improving overall perinatal well-being.
Interventions
- DRUG Prenatal vitamin-mineral containing 3 mg fluoride
- DIETARY_SUPPLEMENT Prenatal vitamin-mineral containing 0 mg fluoride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2015-10 |
| Est. Completion | 2019-10-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02536352
The ClinicalTrials.gov registry entry for NCT02536352 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prenatal vitamin-mineral containing 3 mg fluoride is the first listed.
NCT02536352 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02536352 about?
NCT02536352 is a clinical study titled "Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being". The purpose of this study is to determine whether fluoride supplementation during pregnancy is effective in extending the length of gestation and improving overall perinatal well-being.
What is the current status of trial NCT02536352?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 43 participants. The study started on 2015-10. Estimated completion is 2019-10-01.
What interventions are being tested in trial NCT02536352?
The interventions under investigation include: Prenatal vitamin-mineral containing 3 mg fluoride (DRUG), Prenatal vitamin-mineral containing 0 mg fluoride (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02536352?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.